nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—hypertension—obesity	0.431	1	CtDrD
Furosemide—ALB—obesity	0.0453	1	CbGaD
Furosemide—CA5A—Topiramate—obesity	0.0333	0.0964	CbGbCtD
Furosemide—CA6—Topiramate—obesity	0.0333	0.0964	CbGbCtD
Furosemide—SLC22A11—Cimetidine—obesity	0.0292	0.0846	CbGbCtD
Furosemide—CA5B—Topiramate—obesity	0.029	0.084	CbGbCtD
Furosemide—CA7—Topiramate—obesity	0.029	0.084	CbGbCtD
Furosemide—SLC22A5—Methamphetamine—obesity	0.0266	0.0771	CbGbCtD
Furosemide—CA12—Topiramate—obesity	0.0249	0.0721	CbGbCtD
Furosemide—CA9—Topiramate—obesity	0.0249	0.0721	CbGbCtD
Furosemide—CA1—Topiramate—obesity	0.0233	0.0675	CbGbCtD
Furosemide—CA4—Topiramate—obesity	0.0219	0.0635	CbGbCtD
Furosemide—SLC22A5—Cimetidine—obesity	0.0208	0.0602	CbGbCtD
Furosemide—CA2—Topiramate—obesity	0.0201	0.0583	CbGbCtD
Furosemide—SLC22A8—Cimetidine—obesity	0.017	0.0492	CbGbCtD
Furosemide—SLC22A6—Cimetidine—obesity	0.0118	0.0343	CbGbCtD
Furosemide—ABCC2—bile—obesity	0.00215	0.0726	CbGeAlD
Furosemide—CA9—gall bladder—obesity	0.00124	0.0418	CbGeAlD
Furosemide—CA9—islet of Langerhans—obesity	0.00081	0.0274	CbGeAlD
Furosemide—CA5A—endocrine gland—obesity	0.000688	0.0232	CbGeAlD
Furosemide—SLCO2A1—islet of Langerhans—obesity	0.000637	0.0215	CbGeAlD
Furosemide—ALB—gall bladder—obesity	0.000636	0.0215	CbGeAlD
Furosemide—CA5A—liver—obesity	0.00062	0.021	CbGeAlD
Furosemide—SLCO2A1—respiratory system—obesity	0.000601	0.0203	CbGeAlD
Furosemide—CA4—hindbrain—obesity	0.000574	0.0194	CbGeAlD
Furosemide—PGD—islet of Langerhans—obesity	0.000567	0.0192	CbGeAlD
Furosemide—CA12—respiratory system—obesity	0.000566	0.0191	CbGeAlD
Furosemide—CA7—digestive system—obesity	0.000554	0.0187	CbGeAlD
Furosemide—PGD—respiratory system—obesity	0.000536	0.0181	CbGeAlD
Furosemide—SLCO2A1—adrenal cortex—obesity	0.000504	0.0171	CbGeAlD
Furosemide—CA9—digestive system—obesity	0.000486	0.0164	CbGeAlD
Furosemide—CA2—hindbrain—obesity	0.000476	0.0161	CbGeAlD
Furosemide—CA2—gall bladder—obesity	0.000469	0.0159	CbGeAlD
Furosemide—PGD—adrenal cortex—obesity	0.00045	0.0152	CbGeAlD
Furosemide—CA1—respiratory system—obesity	0.000448	0.0151	CbGeAlD
Furosemide—CA14—adrenal gland—obesity	0.000439	0.0149	CbGeAlD
Furosemide—SLC22A11—digestive system—obesity	0.000426	0.0144	CbGeAlD
Furosemide—PGD—cardiovascular system—obesity	0.00041	0.0139	CbGeAlD
Furosemide—SLCO2A1—pituitary gland—obesity	0.000408	0.0138	CbGeAlD
Furosemide—SLCO2A1—adipose tissue—obesity	0.000406	0.0137	CbGeAlD
Furosemide—CA9—endocrine gland—obesity	0.000402	0.0136	CbGeAlD
Furosemide—CA5B—cardiovascular system—obesity	0.000389	0.0131	CbGeAlD
Furosemide—CA4—islet of Langerhans—obesity	0.000371	0.0125	CbGeAlD
Furosemide—SLCO2A1—adrenal gland—obesity	0.000364	0.0123	CbGeAlD
Furosemide—PGD—pituitary gland—obesity	0.000363	0.0123	CbGeAlD
Furosemide—PGD—adipose tissue—obesity	0.000362	0.0122	CbGeAlD
Furosemide—CA12—digestive system—obesity	0.00036	0.0122	CbGeAlD
Furosemide—SLC22A11—endocrine gland—obesity	0.000352	0.0119	CbGeAlD
Furosemide—CA4—respiratory system—obesity	0.00035	0.0118	CbGeAlD
Furosemide—CA14—liver—obesity	0.000344	0.0116	CbGeAlD
Furosemide—CA1—cardiovascular system—obesity	0.000343	0.0116	CbGeAlD
Furosemide—CA5B—adipose tissue—obesity	0.000343	0.0116	CbGeAlD
Furosemide—PGD—digestive system—obesity	0.000341	0.0115	CbGeAlD
Furosemide—PGD—adrenal gland—obesity	0.000325	0.011	CbGeAlD
Furosemide—SLC22A11—liver—obesity	0.000317	0.0107	CbGeAlD
Furosemide—SLCO2A1—endocrine gland—obesity	0.000316	0.0107	CbGeAlD
Furosemide—CA2—islet of Langerhans—obesity	0.000308	0.0104	CbGeAlD
Furosemide—CA5B—adrenal gland—obesity	0.000307	0.0104	CbGeAlD
Furosemide—CA1—adipose tissue—obesity	0.000303	0.0102	CbGeAlD
Furosemide—CA12—endocrine gland—obesity	0.000297	0.01	CbGeAlD
Furosemide—CA2—respiratory system—obesity	0.00029	0.00982	CbGeAlD
Furosemide—SLC22A5—respiratory system—obesity	0.000286	0.00966	CbGeAlD
Furosemide—CA1—digestive system—obesity	0.000285	0.00963	CbGeAlD
Furosemide—SLCO2A1—liver—obesity	0.000285	0.00962	CbGeAlD
Furosemide—PGD—endocrine gland—obesity	0.000281	0.00951	CbGeAlD
Furosemide—CA4—cardiovascular system—obesity	0.000268	0.00907	CbGeAlD
Furosemide—CA5B—endocrine gland—obesity	0.000267	0.00901	CbGeAlD
Furosemide—PGD—liver—obesity	0.000254	0.00858	CbGeAlD
Furosemide—CA2—adrenal cortex—obesity	0.000244	0.00824	CbGeAlD
Furosemide—SLC22A5—adrenal cortex—obesity	0.00024	0.00811	CbGeAlD
Furosemide—ALB—adrenal gland—obesity	0.000238	0.00806	CbGeAlD
Furosemide—CA4—pituitary gland—obesity	0.000238	0.00803	CbGeAlD
Furosemide—CA4—adipose tissue—obesity	0.000237	0.008	CbGeAlD
Furosemide—CA1—endocrine gland—obesity	0.000235	0.00796	CbGeAlD
Furosemide—ABCC2—digestive system—obesity	0.000235	0.00793	CbGeAlD
Furosemide—ABCC2—adrenal gland—obesity	0.000223	0.00755	CbGeAlD
Furosemide—CA4—digestive system—obesity	0.000223	0.00753	CbGeAlD
Furosemide—CA2—cardiovascular system—obesity	0.000222	0.00752	CbGeAlD
Furosemide—CA1—liver—obesity	0.000212	0.00718	CbGeAlD
Furosemide—CA4—adrenal gland—obesity	0.000212	0.00717	CbGeAlD
Furosemide—CA2—pituitary gland—obesity	0.000197	0.00666	CbGeAlD
Furosemide—CA2—adipose tissue—obesity	0.000196	0.00663	CbGeAlD
Furosemide—SLC22A5—pituitary gland—obesity	0.000194	0.00655	CbGeAlD
Furosemide—ABCC2—endocrine gland—obesity	0.000194	0.00655	CbGeAlD
Furosemide—SLC22A5—adipose tissue—obesity	0.000193	0.00652	CbGeAlD
Furosemide—ALB—liver—obesity	0.000186	0.0063	CbGeAlD
Furosemide—CA2—digestive system—obesity	0.000185	0.00624	CbGeAlD
Furosemide—CA4—endocrine gland—obesity	0.000184	0.00622	CbGeAlD
Furosemide—SLC22A5—digestive system—obesity	0.000182	0.00614	CbGeAlD
Furosemide—CA2—adrenal gland—obesity	0.000176	0.00595	CbGeAlD
Furosemide—ABCC2—liver—obesity	0.000175	0.00591	CbGeAlD
Furosemide—SLC22A5—adrenal gland—obesity	0.000173	0.00585	CbGeAlD
Furosemide—Dizziness—Phenylpropanolamine—obesity	0.000166	0.00214	CcSEcCtD
Furosemide—Diarrhoea—Phentermine—obesity	0.000165	0.00211	CcSEcCtD
Furosemide—Abdominal distension—Bupropion—obesity	0.000164	0.00211	CcSEcCtD
Furosemide—Feeling abnormal—Cimetidine—obesity	0.000164	0.00211	CcSEcCtD
Furosemide—Renal failure—Sibutramine—obesity	0.000164	0.00211	CcSEcCtD
Furosemide—Hepatobiliary disease—Orlistat—obesity	0.000163	0.00209	CcSEcCtD
Furosemide—Sweating—Sibutramine—obesity	0.00016	0.00205	CcSEcCtD
Furosemide—Pancreatitis—Bupropion—obesity	0.00016	0.00205	CcSEcCtD
Furosemide—Vomiting—Phenylpropanolamine—obesity	0.00016	0.00205	CcSEcCtD
Furosemide—Dizziness—Phentermine—obesity	0.000159	0.00204	CcSEcCtD
Furosemide—Rash—Phenylpropanolamine—obesity	0.000159	0.00204	CcSEcCtD
Furosemide—Dermatitis—Phenylpropanolamine—obesity	0.000158	0.00203	CcSEcCtD
Furosemide—Body temperature increased—Cimetidine—obesity	0.000157	0.00202	CcSEcCtD
Furosemide—Vomiting—Phentermine—obesity	0.000153	0.00197	CcSEcCtD
Furosemide—Urinary tract disorder—Orlistat—obesity	0.000153	0.00196	CcSEcCtD
Furosemide—CA2—endocrine gland—obesity	0.000153	0.00516	CbGeAlD
Furosemide—Cramps of lower extremities—Topiramate—obesity	0.000152	0.00195	CcSEcCtD
Furosemide—Urethral disorder—Orlistat—obesity	0.000152	0.00195	CcSEcCtD
Furosemide—Rash—Phentermine—obesity	0.000152	0.00195	CcSEcCtD
Furosemide—Dermatitis—Phentermine—obesity	0.000152	0.00195	CcSEcCtD
Furosemide—Headache—Phentermine—obesity	0.000151	0.00194	CcSEcCtD
Furosemide—Pollakiuria—Bupropion—obesity	0.000151	0.00194	CcSEcCtD
Furosemide—Bladder pain—Topiramate—obesity	0.00015	0.00192	CcSEcCtD
Furosemide—Urine output increased—Topiramate—obesity	0.00015	0.00192	CcSEcCtD
Furosemide—Nausea—Phenylpropanolamine—obesity	0.000149	0.00192	CcSEcCtD
Furosemide—Photosensitivity reaction—Bupropion—obesity	0.000149	0.00191	CcSEcCtD
Furosemide—Hyperglycaemia—Bupropion—obesity	0.000147	0.00189	CcSEcCtD
Furosemide—Hypersensitivity—Cimetidine—obesity	0.000147	0.00188	CcSEcCtD
Furosemide—Visual impairment—Sibutramine—obesity	0.000144	0.00185	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Bupropion—obesity	0.000144	0.00185	CcSEcCtD
Furosemide—Mental disability—Topiramate—obesity	0.000144	0.00185	CcSEcCtD
Furosemide—Diarrhoea—Diethylpropion—obesity	0.000143	0.00184	CcSEcCtD
Furosemide—Nausea—Phentermine—obesity	0.000143	0.00184	CcSEcCtD
Furosemide—Asthenia—Cimetidine—obesity	0.000143	0.00184	CcSEcCtD
Furosemide—Eye disorder—Sibutramine—obesity	0.00014	0.0018	CcSEcCtD
Furosemide—Immune system disorder—Orlistat—obesity	0.00014	0.0018	CcSEcCtD
Furosemide—Tinnitus—Sibutramine—obesity	0.00014	0.00179	CcSEcCtD
Furosemide—Sweating—Bupropion—obesity	0.000139	0.00179	CcSEcCtD
Furosemide—Dizziness—Diethylpropion—obesity	0.000138	0.00178	CcSEcCtD
Furosemide—Diabetes mellitus—Topiramate—obesity	0.000138	0.00178	CcSEcCtD
Furosemide—CA2—liver—obesity	0.000138	0.00465	CbGeAlD
Furosemide—Polyuria—Topiramate—obesity	0.000137	0.00176	CcSEcCtD
Furosemide—Diarrhoea—Cimetidine—obesity	0.000136	0.00175	CcSEcCtD
Furosemide—Angiopathy—Sibutramine—obesity	0.000136	0.00175	CcSEcCtD
Furosemide—SLC22A5—liver—obesity	0.000135	0.00458	CbGeAlD
Furosemide—Immune system disorder—Sibutramine—obesity	0.000135	0.00174	CcSEcCtD
Furosemide—Malnutrition—Orlistat—obesity	0.000135	0.00173	CcSEcCtD
Furosemide—Vascular purpura—Topiramate—obesity	0.000134	0.00173	CcSEcCtD
Furosemide—Deafness—Topiramate—obesity	0.000134	0.00173	CcSEcCtD
Furosemide—Arrhythmia—Sibutramine—obesity	0.000134	0.00172	CcSEcCtD
Furosemide—Vomiting—Diethylpropion—obesity	0.000133	0.00171	CcSEcCtD
Furosemide—Flatulence—Orlistat—obesity	0.000133	0.00171	CcSEcCtD
Furosemide—Rash—Diethylpropion—obesity	0.000132	0.0017	CcSEcCtD
Furosemide—Dysgeusia—Orlistat—obesity	0.000132	0.00169	CcSEcCtD
Furosemide—Dermatitis—Diethylpropion—obesity	0.000132	0.00169	CcSEcCtD
Furosemide—Dizziness—Cimetidine—obesity	0.000132	0.00169	CcSEcCtD
Furosemide—Headache—Diethylpropion—obesity	0.000131	0.00168	CcSEcCtD
Furosemide—Malnutrition—Sibutramine—obesity	0.00013	0.00167	CcSEcCtD
Furosemide—Muscle spasms—Orlistat—obesity	0.00013	0.00166	CcSEcCtD
Furosemide—Urinary tract disorder—Bupropion—obesity	0.000129	0.00166	CcSEcCtD
Furosemide—Flatulence—Sibutramine—obesity	0.000129	0.00165	CcSEcCtD
Furosemide—Urethral disorder—Bupropion—obesity	0.000128	0.00164	CcSEcCtD
Furosemide—Dysgeusia—Sibutramine—obesity	0.000128	0.00164	CcSEcCtD
Furosemide—Vision blurred—Orlistat—obesity	0.000127	0.00163	CcSEcCtD
Furosemide—Vomiting—Cimetidine—obesity	0.000127	0.00163	CcSEcCtD
Furosemide—Thirst—Topiramate—obesity	0.000126	0.00162	CcSEcCtD
Furosemide—Visual impairment—Bupropion—obesity	0.000126	0.00162	CcSEcCtD
Furosemide—Rash—Cimetidine—obesity	0.000126	0.00161	CcSEcCtD
Furosemide—Dermatitis—Cimetidine—obesity	0.000126	0.00161	CcSEcCtD
Furosemide—Muscle spasms—Sibutramine—obesity	0.000125	0.00161	CcSEcCtD
Furosemide—Headache—Cimetidine—obesity	0.000125	0.0016	CcSEcCtD
Furosemide—Purpura—Topiramate—obesity	0.000125	0.0016	CcSEcCtD
Furosemide—Nausea—Diethylpropion—obesity	0.000124	0.0016	CcSEcCtD
Furosemide—Erythema multiforme—Bupropion—obesity	0.000124	0.00159	CcSEcCtD
Furosemide—Vision blurred—Sibutramine—obesity	0.000123	0.00158	CcSEcCtD
Furosemide—Lethargy—Topiramate—obesity	0.000123	0.00158	CcSEcCtD
Furosemide—Eye disorder—Bupropion—obesity	0.000122	0.00157	CcSEcCtD
Furosemide—Tinnitus—Bupropion—obesity	0.000122	0.00156	CcSEcCtD
Furosemide—Vertigo—Orlistat—obesity	0.000121	0.00155	CcSEcCtD
Furosemide—Hyponatraemia—Topiramate—obesity	0.000121	0.00155	CcSEcCtD
Furosemide—Anaemia—Sibutramine—obesity	0.000121	0.00155	CcSEcCtD
Furosemide—Agitation—Sibutramine—obesity	0.00012	0.00154	CcSEcCtD
Furosemide—Angiopathy—Bupropion—obesity	0.000119	0.00152	CcSEcCtD
Furosemide—Nausea—Cimetidine—obesity	0.000118	0.00152	CcSEcCtD
Furosemide—Immune system disorder—Bupropion—obesity	0.000118	0.00151	CcSEcCtD
Furosemide—Vertigo—Sibutramine—obesity	0.000117	0.0015	CcSEcCtD
Furosemide—Leukopenia—Sibutramine—obesity	0.000117	0.0015	CcSEcCtD
Furosemide—Arrhythmia—Bupropion—obesity	0.000117	0.0015	CcSEcCtD
Furosemide—Irritability—Topiramate—obesity	0.000115	0.00147	CcSEcCtD
Furosemide—Urinary retention—Topiramate—obesity	0.000114	0.00147	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000114	0.00146	CcSEcCtD
Furosemide—Malnutrition—Bupropion—obesity	0.000114	0.00146	CcSEcCtD
Furosemide—Blood creatinine increased—Topiramate—obesity	0.000113	0.00145	CcSEcCtD
Furosemide—Dry mouth—Orlistat—obesity	0.000112	0.00144	CcSEcCtD
Furosemide—Flatulence—Bupropion—obesity	0.000112	0.00144	CcSEcCtD
Furosemide—Dehydration—Topiramate—obesity	0.000112	0.00144	CcSEcCtD
Furosemide—Dysgeusia—Bupropion—obesity	0.000111	0.00143	CcSEcCtD
Furosemide—Anaphylactic shock—Orlistat—obesity	0.00011	0.00141	CcSEcCtD
Furosemide—Orthostatic hypotension—Topiramate—obesity	0.00011	0.00141	CcSEcCtD
Furosemide—Hypokalaemia—Topiramate—obesity	0.000109	0.00141	CcSEcCtD
Furosemide—Muscle spasms—Bupropion—obesity	0.000109	0.0014	CcSEcCtD
Furosemide—Dry mouth—Sibutramine—obesity	0.000109	0.00139	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Topiramate—obesity	0.000108	0.00139	CcSEcCtD
Furosemide—Nervous system disorder—Orlistat—obesity	0.000108	0.00139	CcSEcCtD
Furosemide—Confusional state—Sibutramine—obesity	0.000107	0.00138	CcSEcCtD
Furosemide—Vision blurred—Bupropion—obesity	0.000107	0.00138	CcSEcCtD
Furosemide—Skin disorder—Orlistat—obesity	0.000107	0.00137	CcSEcCtD
Furosemide—Anaphylactic shock—Sibutramine—obesity	0.000106	0.00137	CcSEcCtD
Furosemide—Hyperhidrosis—Orlistat—obesity	0.000106	0.00137	CcSEcCtD
Furosemide—Muscular weakness—Topiramate—obesity	0.000106	0.00136	CcSEcCtD
Furosemide—Anaemia—Bupropion—obesity	0.000105	0.00135	CcSEcCtD
Furosemide—Shock—Sibutramine—obesity	0.000105	0.00134	CcSEcCtD
Furosemide—Abdominal distension—Topiramate—obesity	0.000105	0.00134	CcSEcCtD
Furosemide—Agitation—Bupropion—obesity	0.000104	0.00134	CcSEcCtD
Furosemide—Thrombocytopenia—Sibutramine—obesity	0.000104	0.00134	CcSEcCtD
Furosemide—Skin disorder—Sibutramine—obesity	0.000103	0.00133	CcSEcCtD
Furosemide—Eosinophilia—Topiramate—obesity	0.000103	0.00132	CcSEcCtD
Furosemide—Hyperhidrosis—Sibutramine—obesity	0.000103	0.00132	CcSEcCtD
Furosemide—Vertigo—Bupropion—obesity	0.000102	0.00131	CcSEcCtD
Furosemide—Pancreatitis—Topiramate—obesity	0.000102	0.00131	CcSEcCtD
Furosemide—Leukopenia—Bupropion—obesity	0.000102	0.00131	CcSEcCtD
Furosemide—Anorexia—Sibutramine—obesity	0.000101	0.0013	CcSEcCtD
Furosemide—Hypotension—Sibutramine—obesity	9.95e-05	0.00128	CcSEcCtD
Furosemide—Paraesthesia—Orlistat—obesity	9.88e-05	0.00127	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	9.61e-05	0.00123	CcSEcCtD
Furosemide—Pollakiuria—Topiramate—obesity	9.6e-05	0.00123	CcSEcCtD
Furosemide—Decreased appetite—Orlistat—obesity	9.56e-05	0.00123	CcSEcCtD
Furosemide—Paraesthesia—Sibutramine—obesity	9.56e-05	0.00123	CcSEcCtD
Furosemide—Gastrointestinal disorder—Orlistat—obesity	9.5e-05	0.00122	CcSEcCtD
Furosemide—Photosensitivity reaction—Topiramate—obesity	9.49e-05	0.00122	CcSEcCtD
Furosemide—Fatigue—Orlistat—obesity	9.48e-05	0.00122	CcSEcCtD
Furosemide—Dry mouth—Bupropion—obesity	9.47e-05	0.00122	CcSEcCtD
Furosemide—Somnolence—Sibutramine—obesity	9.46e-05	0.00122	CcSEcCtD
Furosemide—Pain—Orlistat—obesity	9.41e-05	0.00121	CcSEcCtD
Furosemide—Hyperglycaemia—Topiramate—obesity	9.38e-05	0.0012	CcSEcCtD
Furosemide—Confusional state—Bupropion—obesity	9.36e-05	0.0012	CcSEcCtD
Furosemide—Anaphylactic shock—Bupropion—obesity	9.28e-05	0.00119	CcSEcCtD
Furosemide—Decreased appetite—Sibutramine—obesity	9.25e-05	0.00119	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Topiramate—obesity	9.19e-05	0.00118	CcSEcCtD
Furosemide—Gastrointestinal disorder—Sibutramine—obesity	9.19e-05	0.00118	CcSEcCtD
Furosemide—Shock—Bupropion—obesity	9.13e-05	0.00117	CcSEcCtD
Furosemide—Renal failure—Topiramate—obesity	9.11e-05	0.00117	CcSEcCtD
Furosemide—Pain—Sibutramine—obesity	9.1e-05	0.00117	CcSEcCtD
Furosemide—Constipation—Sibutramine—obesity	9.1e-05	0.00117	CcSEcCtD
Furosemide—Nervous system disorder—Bupropion—obesity	9.1e-05	0.00117	CcSEcCtD
Furosemide—Thrombocytopenia—Bupropion—obesity	9.09e-05	0.00117	CcSEcCtD
Furosemide—Feeling abnormal—Orlistat—obesity	9.06e-05	0.00116	CcSEcCtD
Furosemide—Skin disorder—Bupropion—obesity	9.01e-05	0.00116	CcSEcCtD
Furosemide—Gastrointestinal pain—Orlistat—obesity	8.99e-05	0.00115	CcSEcCtD
Furosemide—Hyperhidrosis—Bupropion—obesity	8.97e-05	0.00115	CcSEcCtD
Furosemide—Anorexia—Bupropion—obesity	8.85e-05	0.00114	CcSEcCtD
Furosemide—Feeling abnormal—Sibutramine—obesity	8.77e-05	0.00113	CcSEcCtD
Furosemide—Urticaria—Orlistat—obesity	8.74e-05	0.00112	CcSEcCtD
Furosemide—Gastrointestinal pain—Sibutramine—obesity	8.7e-05	0.00112	CcSEcCtD
Furosemide—Abdominal pain—Orlistat—obesity	8.69e-05	0.00112	CcSEcCtD
Furosemide—Body temperature increased—Orlistat—obesity	8.69e-05	0.00112	CcSEcCtD
Furosemide—Hypotension—Bupropion—obesity	8.67e-05	0.00111	CcSEcCtD
Furosemide—Agranulocytosis—Topiramate—obesity	8.65e-05	0.00111	CcSEcCtD
Furosemide—Urticaria—Sibutramine—obesity	8.46e-05	0.00109	CcSEcCtD
Furosemide—Body temperature increased—Sibutramine—obesity	8.41e-05	0.00108	CcSEcCtD
Furosemide—Abdominal pain—Sibutramine—obesity	8.41e-05	0.00108	CcSEcCtD
Furosemide—Paraesthesia—Bupropion—obesity	8.33e-05	0.00107	CcSEcCtD
Furosemide—Somnolence—Bupropion—obesity	8.25e-05	0.00106	CcSEcCtD
Furosemide—Urinary tract disorder—Topiramate—obesity	8.22e-05	0.00106	CcSEcCtD
Furosemide—Urethral disorder—Topiramate—obesity	8.16e-05	0.00105	CcSEcCtD
Furosemide—Hypersensitivity—Orlistat—obesity	8.1e-05	0.00104	CcSEcCtD
Furosemide—Decreased appetite—Bupropion—obesity	8.07e-05	0.00104	CcSEcCtD
Furosemide—Visual impairment—Topiramate—obesity	8.02e-05	0.00103	CcSEcCtD
Furosemide—Gastrointestinal disorder—Bupropion—obesity	8.01e-05	0.00103	CcSEcCtD
Furosemide—Fatigue—Bupropion—obesity	8e-05	0.00103	CcSEcCtD
Furosemide—Pain—Bupropion—obesity	7.94e-05	0.00102	CcSEcCtD
Furosemide—Constipation—Bupropion—obesity	7.94e-05	0.00102	CcSEcCtD
Furosemide—Asthenia—Orlistat—obesity	7.89e-05	0.00101	CcSEcCtD
Furosemide—Erythema multiforme—Topiramate—obesity	7.87e-05	0.00101	CcSEcCtD
Furosemide—Hypersensitivity—Sibutramine—obesity	7.84e-05	0.00101	CcSEcCtD
Furosemide—Pruritus—Orlistat—obesity	7.78e-05	0.000999	CcSEcCtD
Furosemide—Eye disorder—Topiramate—obesity	7.78e-05	0.000999	CcSEcCtD
Furosemide—Tinnitus—Topiramate—obesity	7.76e-05	0.000996	CcSEcCtD
Furosemide—Feeling abnormal—Bupropion—obesity	7.65e-05	0.000982	CcSEcCtD
Furosemide—Asthenia—Sibutramine—obesity	7.64e-05	0.000981	CcSEcCtD
Furosemide—Gastrointestinal pain—Bupropion—obesity	7.59e-05	0.000974	CcSEcCtD
Furosemide—Angiopathy—Topiramate—obesity	7.55e-05	0.00097	CcSEcCtD
Furosemide—Pruritus—Sibutramine—obesity	7.53e-05	0.000967	CcSEcCtD
Furosemide—Diarrhoea—Orlistat—obesity	7.53e-05	0.000966	CcSEcCtD
Furosemide—Immune system disorder—Topiramate—obesity	7.52e-05	0.000965	CcSEcCtD
Furosemide—Urticaria—Bupropion—obesity	7.37e-05	0.000947	CcSEcCtD
Furosemide—Abdominal pain—Bupropion—obesity	7.34e-05	0.000942	CcSEcCtD
Furosemide—Body temperature increased—Bupropion—obesity	7.34e-05	0.000942	CcSEcCtD
Furosemide—Diarrhoea—Sibutramine—obesity	7.28e-05	0.000935	CcSEcCtD
Furosemide—Dizziness—Orlistat—obesity	7.27e-05	0.000934	CcSEcCtD
Furosemide—Erythema—Topiramate—obesity	7.24e-05	0.00093	CcSEcCtD
Furosemide—Malnutrition—Topiramate—obesity	7.24e-05	0.00093	CcSEcCtD
Furosemide—Flatulence—Topiramate—obesity	7.14e-05	0.000917	CcSEcCtD
Furosemide—Dysgeusia—Topiramate—obesity	7.09e-05	0.000911	CcSEcCtD
Furosemide—Dizziness—Sibutramine—obesity	7.04e-05	0.000904	CcSEcCtD
Furosemide—Vomiting—Orlistat—obesity	6.99e-05	0.000898	CcSEcCtD
Furosemide—Muscle spasms—Topiramate—obesity	6.96e-05	0.000894	CcSEcCtD
Furosemide—Rash—Orlistat—obesity	6.94e-05	0.000891	CcSEcCtD
Furosemide—Dermatitis—Orlistat—obesity	6.93e-05	0.00089	CcSEcCtD
Furosemide—Headache—Orlistat—obesity	6.89e-05	0.000885	CcSEcCtD
Furosemide—Hypersensitivity—Bupropion—obesity	6.84e-05	0.000878	CcSEcCtD
Furosemide—Vision blurred—Topiramate—obesity	6.83e-05	0.000877	CcSEcCtD
Furosemide—Vomiting—Sibutramine—obesity	6.77e-05	0.000869	CcSEcCtD
Furosemide—Rash—Sibutramine—obesity	6.71e-05	0.000862	CcSEcCtD
Furosemide—Dermatitis—Sibutramine—obesity	6.71e-05	0.000861	CcSEcCtD
Furosemide—Anaemia—Topiramate—obesity	6.7e-05	0.00086	CcSEcCtD
Furosemide—Headache—Sibutramine—obesity	6.67e-05	0.000856	CcSEcCtD
Furosemide—Asthenia—Bupropion—obesity	6.66e-05	0.000855	CcSEcCtD
Furosemide—Agitation—Topiramate—obesity	6.66e-05	0.000855	CcSEcCtD
Furosemide—Pruritus—Bupropion—obesity	6.57e-05	0.000843	CcSEcCtD
Furosemide—Nausea—Orlistat—obesity	6.53e-05	0.000839	CcSEcCtD
Furosemide—Vertigo—Topiramate—obesity	6.51e-05	0.000836	CcSEcCtD
Furosemide—Leukopenia—Topiramate—obesity	6.48e-05	0.000833	CcSEcCtD
Furosemide—Diarrhoea—Bupropion—obesity	6.35e-05	0.000815	CcSEcCtD
Furosemide—Nausea—Sibutramine—obesity	6.32e-05	0.000812	CcSEcCtD
Furosemide—Dizziness—Bupropion—obesity	6.14e-05	0.000788	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	6.12e-05	0.000786	CcSEcCtD
Furosemide—Dry mouth—Topiramate—obesity	6.03e-05	0.000775	CcSEcCtD
Furosemide—Confusional state—Topiramate—obesity	5.96e-05	0.000765	CcSEcCtD
Furosemide—Vomiting—Bupropion—obesity	5.9e-05	0.000758	CcSEcCtD
Furosemide—Rash—Bupropion—obesity	5.85e-05	0.000751	CcSEcCtD
Furosemide—Dermatitis—Bupropion—obesity	5.85e-05	0.000751	CcSEcCtD
Furosemide—Shock—Topiramate—obesity	5.82e-05	0.000747	CcSEcCtD
Furosemide—Headache—Bupropion—obesity	5.81e-05	0.000747	CcSEcCtD
Furosemide—Nervous system disorder—Topiramate—obesity	5.8e-05	0.000745	CcSEcCtD
Furosemide—Thrombocytopenia—Topiramate—obesity	5.79e-05	0.000743	CcSEcCtD
Furosemide—Skin disorder—Topiramate—obesity	5.74e-05	0.000737	CcSEcCtD
Furosemide—Hyperhidrosis—Topiramate—obesity	5.72e-05	0.000734	CcSEcCtD
Furosemide—Anorexia—Topiramate—obesity	5.64e-05	0.000724	CcSEcCtD
Furosemide—Hypotension—Topiramate—obesity	5.52e-05	0.000709	CcSEcCtD
Furosemide—Nausea—Bupropion—obesity	5.51e-05	0.000708	CcSEcCtD
Furosemide—Paraesthesia—Topiramate—obesity	5.31e-05	0.000682	CcSEcCtD
Furosemide—Somnolence—Topiramate—obesity	5.26e-05	0.000675	CcSEcCtD
Furosemide—Decreased appetite—Topiramate—obesity	5.14e-05	0.00066	CcSEcCtD
Furosemide—Gastrointestinal disorder—Topiramate—obesity	5.1e-05	0.000655	CcSEcCtD
Furosemide—Fatigue—Topiramate—obesity	5.1e-05	0.000655	CcSEcCtD
Furosemide—Pain—Topiramate—obesity	5.06e-05	0.000649	CcSEcCtD
Furosemide—Constipation—Topiramate—obesity	5.06e-05	0.000649	CcSEcCtD
Furosemide—Feeling abnormal—Topiramate—obesity	4.87e-05	0.000626	CcSEcCtD
Furosemide—Gastrointestinal pain—Topiramate—obesity	4.83e-05	0.000621	CcSEcCtD
Furosemide—Urticaria—Topiramate—obesity	4.7e-05	0.000603	CcSEcCtD
Furosemide—Abdominal pain—Topiramate—obesity	4.67e-05	0.0006	CcSEcCtD
Furosemide—Body temperature increased—Topiramate—obesity	4.67e-05	0.0006	CcSEcCtD
Furosemide—Hypersensitivity—Topiramate—obesity	4.36e-05	0.000559	CcSEcCtD
Furosemide—Asthenia—Topiramate—obesity	4.24e-05	0.000545	CcSEcCtD
Furosemide—Pruritus—Topiramate—obesity	4.18e-05	0.000537	CcSEcCtD
Furosemide—Diarrhoea—Topiramate—obesity	4.05e-05	0.000519	CcSEcCtD
Furosemide—Dizziness—Topiramate—obesity	3.91e-05	0.000502	CcSEcCtD
Furosemide—Vomiting—Topiramate—obesity	3.76e-05	0.000483	CcSEcCtD
Furosemide—Rash—Topiramate—obesity	3.73e-05	0.000479	CcSEcCtD
Furosemide—Dermatitis—Topiramate—obesity	3.72e-05	0.000478	CcSEcCtD
Furosemide—Headache—Topiramate—obesity	3.7e-05	0.000476	CcSEcCtD
Furosemide—Nausea—Topiramate—obesity	3.51e-05	0.000451	CcSEcCtD
Furosemide—CA2—Metabolism—APOA1—obesity	4.59e-06	6.43e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—SERPINE1—obesity	4.59e-06	6.41e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PTPN1—obesity	4.58e-06	6.41e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—FASN—obesity	4.58e-06	6.4e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—BCHE—obesity	4.56e-06	6.38e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—GPX1—obesity	4.56e-06	6.38e-05	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL6—obesity	4.56e-06	6.37e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3R1—obesity	4.55e-06	6.37e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—NOS3—obesity	4.55e-06	6.37e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—AGT—obesity	4.55e-06	6.36e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CB—obesity	4.54e-06	6.35e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CB—obesity	4.54e-06	6.35e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HMGCS1—obesity	4.52e-06	6.32e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTGS2—obesity	4.5e-06	6.29e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTGS2—obesity	4.5e-06	6.29e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOE—obesity	4.45e-06	6.23e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—CD36—obesity	4.44e-06	6.21e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—RHOA—obesity	4.42e-06	6.19e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—CAV1—obesity	4.41e-06	6.17e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOA1—obesity	4.4e-06	6.16e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PNPLA2—obesity	4.39e-06	6.13e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLIN1—obesity	4.39e-06	6.13e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PFKFB3—obesity	4.39e-06	6.13e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ANGPTL4—obesity	4.39e-06	6.13e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ACADM—obesity	4.39e-06	6.13e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SAT1—obesity	4.39e-06	6.13e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3R1—obesity	4.38e-06	6.12e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CG—obesity	4.37e-06	6.12e-05	CbGpPWpGaD
Furosemide—PGD—Disease—STAT3—obesity	4.33e-06	6.05e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ACACB—obesity	4.27e-06	5.97e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYTB—obesity	4.27e-06	5.97e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—OXCT1—obesity	4.27e-06	5.97e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLG—obesity	4.26e-06	5.96e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PPARG—obesity	4.22e-06	5.91e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—MTHFR—obesity	4.21e-06	5.88e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CB—obesity	4.2e-06	5.88e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CG—obesity	4.19e-06	5.87e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTGS2—obesity	4.16e-06	5.83e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—POMC—obesity	4.16e-06	5.82e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PNLIP—obesity	4.16e-06	5.81e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SRD5A1—obesity	4.16e-06	5.81e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—INS—obesity	4.14e-06	5.79e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPARA—obesity	4.13e-06	5.77e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SDC3—obesity	4.06e-06	5.68e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PPARG—obesity	4.05e-06	5.66e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CB—obesity	4.04e-06	5.65e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—GGT1—obesity	4.04e-06	5.65e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CG—obesity	4.02e-06	5.62e-05	CbGpPWpGaD
Furosemide—PGD—Disease—MYC—obesity	4.02e-06	5.62e-05	CbGpPWpGaD
Furosemide—PGD—Disease—TGFB1—obesity	4.01e-06	5.61e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—AGT—obesity	4e-06	5.59e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—POMC—obesity	3.99e-06	5.58e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—NCOA1—obesity	3.98e-06	5.56e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—INS—obesity	3.97e-06	5.55e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—STS—obesity	3.97e-06	5.55e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HK2—obesity	3.97e-06	5.55e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP26B1—obesity	3.97e-06	5.55e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—SLC2A4—obesity	3.96e-06	5.55e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—GNB3—obesity	3.95e-06	5.52e-05	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ALB—obesity	3.93e-06	5.5e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—obesity	3.92e-06	5.48e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOE—obesity	3.92e-06	5.48e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—CYCS—obesity	3.91e-06	5.47e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARD—obesity	3.88e-06	5.43e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PPARG—obesity	3.88e-06	5.43e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—CAV1—obesity	3.88e-06	5.43e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IGF2—obesity	3.88e-06	5.42e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOA1—obesity	3.87e-06	5.42e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CD—obesity	3.85e-06	5.38e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—GNAS—obesity	3.84e-06	5.38e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—POMC—obesity	3.83e-06	5.35e-05	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ALB—obesity	3.81e-06	5.32e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—INS—obesity	3.81e-06	5.32e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC27A1—obesity	3.8e-06	5.32e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—ALB—obesity	3.8e-06	5.31e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—NCOA1—obesity	3.78e-06	5.29e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—APOB—obesity	3.76e-06	5.26e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GLUL—obesity	3.73e-06	5.22e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—FABP4—obesity	3.73e-06	5.22e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CD—obesity	3.69e-06	5.16e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—PLG—obesity	3.69e-06	5.16e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—ALB—obesity	3.64e-06	5.09e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3R1—obesity	3.63e-06	5.08e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—NOS3—obesity	3.63e-06	5.08e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	3.59e-06	5.03e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ECHS1—obesity	3.53e-06	4.94e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—UCP2—obesity	3.53e-06	4.94e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—UCP3—obesity	3.53e-06	4.94e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HSD11B1—obesity	3.53e-06	4.94e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CG—obesity	3.53e-06	4.94e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CD—obesity	3.53e-06	4.94e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—ALB—obesity	3.49e-06	4.88e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—NOS3—obesity	3.48e-06	4.87e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3R1—obesity	3.48e-06	4.87e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ADH1B—obesity	3.48e-06	4.86e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOB—obesity	3.43e-06	4.79e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ACSL1—obesity	3.42e-06	4.79e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GPAM—obesity	3.42e-06	4.79e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARGC1B—obesity	3.42e-06	4.79e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—GNB3—obesity	3.42e-06	4.78e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CD36—obesity	3.41e-06	4.78e-05	CbGpPWpGaD
Furosemide—PGD—Disease—PIK3CA—obesity	3.41e-06	4.77e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPARG—obesity	3.41e-06	4.77e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—HMOX1—obesity	3.4e-06	4.76e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—POMC—obesity	3.36e-06	4.71e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CB—obesity	3.35e-06	4.69e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—INS—obesity	3.35e-06	4.68e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3R1—obesity	3.34e-06	4.67e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—NOS3—obesity	3.34e-06	4.67e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—GNAS—obesity	3.33e-06	4.65e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HADH—obesity	3.32e-06	4.65e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—FADS1—obesity	3.32e-06	4.65e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PCK1—obesity	3.32e-06	4.65e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTGS2—obesity	3.32e-06	4.65e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PRKCD—obesity	3.31e-06	4.63e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—LPL—obesity	3.27e-06	4.58e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—APOB—obesity	3.26e-06	4.56e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ACP5—obesity	3.23e-06	4.52e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CB—obesity	3.21e-06	4.49e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—GPX1—obesity	3.19e-06	4.46e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTGS2—obesity	3.18e-06	4.45e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—G6PD—obesity	3.15e-06	4.41e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SREBF2—obesity	3.11e-06	4.35e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HK1—obesity	3.11e-06	4.35e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CD36—obesity	3.11e-06	4.35e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CD—obesity	3.11e-06	4.35e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CB—obesity	3.08e-06	4.31e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—ALB—obesity	3.07e-06	4.29e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS2—obesity	3.05e-06	4.27e-05	CbGpPWpGaD
Furosemide—CA14—Metabolism—PIK3CA—obesity	3.04e-06	4.25e-05	CbGpPWpGaD
Furosemide—PGD—Disease—IL6—obesity	3.02e-06	4.23e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—LPA—obesity	3.01e-06	4.2e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CAV1—obesity	2.98e-06	4.17e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—APOA1—obesity	2.98e-06	4.17e-05	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PIK3CA—obesity	2.96e-06	4.14e-05	CbGpPWpGaD
Furosemide—CA6—Metabolism—PIK3CA—obesity	2.96e-06	4.14e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—LPIN1—obesity	2.94e-06	4.11e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3R1—obesity	2.93e-06	4.1e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—NOS3—obesity	2.93e-06	4.1e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—TGFB1—obesity	2.9e-06	4.05e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PPARA—obesity	2.89e-06	4.04e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOA5—obesity	2.88e-06	4.03e-05	CbGpPWpGaD
Furosemide—PGD—Metabolism—PIK3CA—obesity	2.86e-06	4e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—F2—obesity	2.84e-06	3.97e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PRKCB—obesity	2.84e-06	3.97e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—AGT—obesity	2.8e-06	3.92e-05	CbGpPWpGaD
Furosemide—PGD—Disease—AKT1—obesity	2.79e-06	3.9e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PIK3CA—obesity	2.77e-06	3.87e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—PIK3CA—obesity	2.77e-06	3.87e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CLOCK—obesity	2.75e-06	3.85e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC22A1—obesity	2.75e-06	3.85e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—PPARA—obesity	2.75e-06	3.84e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOE—obesity	2.74e-06	3.84e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CG—obesity	2.72e-06	3.8e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CAV1—obesity	2.72e-06	3.8e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOA1—obesity	2.71e-06	3.79e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CB—obesity	2.71e-06	3.79e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS2—obesity	2.68e-06	3.75e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SULT2A1—obesity	2.68e-06	3.75e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GLP1R—obesity	2.68e-06	3.75e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—DPYD—obesity	2.64e-06	3.69e-05	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—APOA1—obesity	2.58e-06	3.61e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—PIK3CA—obesity	2.56e-06	3.58e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PRKAR2B—obesity	2.54e-06	3.55e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—DCN—obesity	2.52e-06	3.52e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IGF1—obesity	2.49e-06	3.48e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—AKT2—obesity	2.49e-06	3.48e-05	CbGpPWpGaD
Furosemide—CA14—Metabolism—AKT1—obesity	2.48e-06	3.47e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—obesity	2.48e-06	3.46e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PIK3CA—obesity	2.46e-06	3.45e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CPT1A—obesity	2.45e-06	3.43e-05	CbGpPWpGaD
Furosemide—CA5A—Metabolism—AKT1—obesity	2.42e-06	3.39e-05	CbGpPWpGaD
Furosemide—CA6—Metabolism—AKT1—obesity	2.42e-06	3.39e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—NAMPT—obesity	2.4e-06	3.36e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CD—obesity	2.39e-06	3.34e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PPARG—obesity	2.39e-06	3.34e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—LIPC—obesity	2.39e-06	3.34e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GCK—obesity	2.39e-06	3.34e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOC3—obesity	2.37e-06	3.32e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SERPINE1—obesity	2.36e-06	3.31e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—POMC—obesity	2.36e-06	3.3e-05	CbGpPWpGaD
Furosemide—PGD—Metabolism—AKT1—obesity	2.33e-06	3.27e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CETP—obesity	2.3e-06	3.22e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—RHOA—obesity	2.28e-06	3.19e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SDC1—obesity	2.28e-06	3.19e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—AKT1—obesity	2.26e-06	3.16e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—AKT1—obesity	2.26e-06	3.16e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3R1—obesity	2.26e-06	3.16e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NOS3—obesity	2.26e-06	3.16e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—AKR1C3—obesity	2.24e-06	3.13e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SCARB1—obesity	2.21e-06	3.09e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—obesity	2.18e-06	3.04e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SREBF1—obesity	2.14e-06	3e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—AKT1—obesity	2.09e-06	2.93e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GOT2—obesity	2.08e-06	2.91e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CB—obesity	2.08e-06	2.91e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3R1—obesity	2.05e-06	2.87e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—PIK3CA—obesity	2.04e-06	2.86e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—FASN—obesity	2.04e-06	2.85e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—BCHE—obesity	2.03e-06	2.84e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—AKT1—obesity	2.01e-06	2.82e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—PIK3CA—obesity	1.96e-06	2.74e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP2E1—obesity	1.96e-06	2.74e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—NQO1—obesity	1.94e-06	2.71e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.9e-06	2.65e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.88e-06	2.63e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PIK3CA—obesity	1.88e-06	2.63e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GCG—obesity	1.86e-06	2.6e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—SLC2A4—obesity	1.86e-06	2.6e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYCS—obesity	1.83e-06	2.56e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GGT1—obesity	1.8e-06	2.52e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GOT1—obesity	1.8e-06	2.52e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—NCOA1—obesity	1.77e-06	2.48e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—STK11—obesity	1.75e-06	2.44e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP19A1—obesity	1.75e-06	2.44e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—AKT1—obesity	1.67e-06	2.33e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PIK3CA—obesity	1.65e-06	2.31e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—COMT—obesity	1.62e-06	2.27e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GNB3—obesity	1.6e-06	2.24e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARGC1A—obesity	1.6e-06	2.24e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—AKT1—obesity	1.6e-06	2.24e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HMOX1—obesity	1.59e-06	2.23e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GNAS—obesity	1.56e-06	2.18e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—AKT1—obesity	1.53e-06	2.15e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOB—obesity	1.53e-06	2.13e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TGFB1—obesity	1.49e-06	2.09e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—LPL—obesity	1.46e-06	2.04e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GPX1—obesity	1.42e-06	1.99e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CD36—obesity	1.38e-06	1.94e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—AKT1—obesity	1.35e-06	1.89e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—MTHFR—obesity	1.31e-06	1.84e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARA—obesity	1.29e-06	1.8e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PIK3CA—obesity	1.27e-06	1.78e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—AGT—obesity	1.25e-06	1.74e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOE—obesity	1.22e-06	1.71e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CAV1—obesity	1.21e-06	1.69e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOA1—obesity	1.21e-06	1.69e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.16e-06	1.62e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CG—obesity	1.1e-06	1.54e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARG—obesity	1.06e-06	1.49e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—POMC—obesity	1.05e-06	1.47e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—INS—obesity	1.04e-06	1.46e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—AKT1—obesity	1.04e-06	1.45e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CD—obesity	9.69e-07	1.36e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—NOS3—obesity	9.15e-07	1.28e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3R1—obesity	9.15e-07	1.28e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CB—obesity	8.45e-07	1.18e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS2—obesity	8.37e-07	1.17e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PIK3CA—obesity	5.15e-07	7.2e-06	CbGpPWpGaD
Furosemide—ALB—Metabolism—AKT1—obesity	4.21e-07	5.88e-06	CbGpPWpGaD
